Navigation Links
Dominion Diagnostics Supports Opioid Risk Management Program for Fourth Consecutive Year
Date:6/8/2011

NORTH KINGSTOWN, R.I., June 8, 2011 /PRNewswire/ -- Leading national medication monitoring company, Dominion Diagnostics, announces its support of Tufts Health Care Institute's (THCI) Program on Opioid Risk Management for a fourth consecutive year.

Dominion's support of THCI's Program on Opioid Risk Management began in 2007 as part of the company's commitment to promoting the safe and effective use of controlled opioid medications commonly prescribed for chronic pain patients.  The Program aims to address the need to provide chronic pain patients with adequate opioid pharmacotherapy that enhances individual patient care while simultaneously reducing the risk of abuse and/or diversion.

"The mission of THCI's Opioid Risk Management Program is paramount to raising the standard of care for chronic pain patients and addressing the rapidly growing epidemic of prescription drug misuse," says Bob Garvey, Dominion's Chief Executive Officer. "It has become essential to engage such a diverse group of stakeholders in the development and implementation of programs that support prescription adherence, improve patient outcomes, and minimize risk through education, innovative clinical support, and evidence-based quality care."

Through a series of summit meetings each year, the THCI Opioid Risk Management Program provides a unique educational forum to encourage discussion among industry thought leaders.  Summit meeting participants, including Dominion's representatives, review scientific and health industry findings relevant to opioid risk management, and discuss recommendations for future initiatives. The THCI Opioid Risk Management Program has distinguished itself nationally as a high value medium for its exchange of ideas, implementation of awareness goals, and resulting collaborations for research and publication.

Dominion will participate in a two-day summit this week that will focus on pharmacotherapy for prescription opioid addiction and the implications for pain management with other participants in the THCI Opioid Risk Management Program.  For more information on the THCI Opioid Risk Management Program, please visit www.thci.org/opioid.

About Dominion Diagnostics  

Dominion Diagnostics is a leading national medication monitoring company that offers comprehensive drug testing, scientifically accurate medication monitoring services and a full suite of clinical support solutions. Since 1997, Dominion has provided services to thousands of clients representing a diversity of medical specialties across the United States, including pain medicine, addiction medicine, behavioral health, primary care, psychiatry, and hospital systems.  Dominion is supported by a world-class team that shares a commitment to clinical and operational excellence.  For more information, please visit www.dominiondiagnostics.com.

For Media Inquiries, contact:
Julie K. Lenahan, MBA, Director of Marketing
Tel: (401) 667-0876, E-Mail: jlenahan@dominiondiagnostics.com


'/>"/>
SOURCE Dominion Diagnostics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials
2. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
3. Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference
4. Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
5. Boston Heart Lab Changes Name to Boston Heart Diagnostics
6. Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients
7. Quest Diagnostics Successfully Completes Acquisition of Celera
8. Quest Diagnostics Declares Quarterly Cash Dividend
9. eCardio Diagnostics Announces Three Executive Appointments to Chief Operating Officer, Chief Technology Officer and Executive Vice President
10. VIDA Diagnostics Launches Apollo Pulmonary Analysis Software for Major Lung Disease at American Thoracic Society Meeting
11. Siemens Showcases New Innovations in Clinical Diagnostics, Automation, and IT at IFCC-WorldLab Berlin 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
(Date:4/27/2016)...   , ... le trimestre, soutenu par une croissance de +42% ... de +16% des ventes aux hôpitaux et cliniques  ... (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de Cellvizio®, ... chiffre d,affaires pour le premier trimestre clos au ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Dr. Bernie Siegel, (M.D.) ... MEDICINE and MIRACLES") addresses touchy topics related to Death live on Dr. ... Dr. Bernie Siegel, author of a plethora of essential books-to-read for physicians and ...
(Date:4/29/2016)... ... 2016 , ... Coast Dental Fort Stewart is celebrating its grand opening with ... Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, ... will have the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, ...
(Date:4/29/2016)... PA (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the ... Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon ... a very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer ... a procedure that involves one or both jaw bones. This surgery is performed to correct ...
Breaking Medicine News(10 mins):